Safety Labeling Changes for Erythropoiesis-Stimulating Agents (ESAs)

The FDA press release below is important to some men with prostate cancer. If you are currently taking Aranesp, Epogen or Procrit you should talk to your doctor about your risks and potential benefits. FDA Strengthens Boxed Warnings, Approves Other Safety Labeling Changes for Erythropoiesis-Stimulating Agents (ESAs) The U.S. Food and Drug Administration today approved [...]

By |2017-10-19T10:58:55-04:00November 14th, 2007|Activism, Treatment News|0 Comments

Walking helps men with prostate cancer

Take you dog for a walk. Enjoy walking with your wife. Walk around your neighborhood and enjoy these fall days. It will help you to deal with your prostate cancer and treatment side effects. Yesterday while in town I observed a gentleman in his 80's jogging while talking on his cellphone. I have a neighbor [...]

By |2020-02-04T11:48:05-05:00October 29th, 2007|Treatment News|0 Comments

Image Guided Therapy improves radiation QOL outcomes

The Oregon Health & Science University Cancer Institute using tiny gold pellets has lessened rectal problems with radiation treatments. Oregon Health & Science University Cancer Institute researchers have found that highly targeted radiation therapy for prostate cancer can ensure that the majority of persons with this tumor will not have any long-term rectal damage. A [...]

By |2020-02-04T11:48:01-05:00October 29th, 2007|Treatment News|0 Comments

New resource for patients and advocates-good-quality cancer care

A new Institute of Medicine(IOM) reports focus on changing the dynamic of cancer care to include the impacts of coping with a diagnosis and treatment for cancer. As patients are surviving longer than they have in the past these issues become more and more important. By addressing these quality of life issues the patient, the [...]

By |2020-02-04T08:34:33-05:00October 25th, 2007|Tools for Activists, Treatment News|1 Comment

Focal therapy for prostate cancer

Scott E. Eggener, Peter T. Scardino, Peter R. Carroll, Michael J. Zelefsky, Oliver Sartor, Hedvig Hricak, Thomas M. Wheeler, Samson W. Fine, John Trachtenberg, Mark A. Rubin, Mak Ohori, Kentaro Kuroiwa, Michel Rossignol, Lucien Abenhaim and International Task Force on Prostate Cancer and the Focal Lesion Paradigm has published a paper in the Journal of [...]

By |2020-02-04T08:33:27-05:00October 17th, 2007|Treatment News|0 Comments

Potential new treatment avenue in the future

 More research reported at the recent Prostate Cancer Research Foundationmeeting that may impact the treatment of prostate cancer and possibly breast cancer also. Lead researcher William Nelson, M.D., Ph.D., Professor of Oncology and Urology at the Johns Hopkins Kimmel Cancer Center, explained the findings. "One of the proteins in the cell that triggers this process [...]

By |2020-02-04T08:33:24-05:00October 17th, 2007|Treatment News|2 Comments

Study reports 5 year experience for robotic surgery

New patients considering their options will be interested in the information from this early study on robotic surgery. To the authors' knowledge, the current study is the first report of 5-year outcomes in men undergoing RAP. These data demonstrate that RAP can be performed with favorable outcomes while minimizing complications. As experience increases, further improvements [...]

By |2020-02-04T08:33:20-05:00October 15th, 2007|Treatment News|2 Comments
Go to Top